OII vs CLOV

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus 4. 6% for Oceaneering International, Inc. (OII). Oceaneering International, Inc. (OII) offers the better valuation at 10. 5x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Oceaneering International, Inc. (OII) a "Hold" — based on 44 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Oceaneering International, Inc.

is actually cheaper at 20. 5x.

Over the past 5 years, Oceaneering International, Inc.

(OII) delivered a total return of +137. 5%, compared to -67. 3% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: OII returned +16. 7% versus CLOV's -72. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Oceaneering International, Inc.

(OII) is the lower-risk stock at 1. 06β versus Clover Health Investments, Corp. 's 1. 22β — meaning CLOV is approximately 15% more volatile than OII relative to the S&P 500.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus 4. 6% for Oceaneering International, Inc. (OII). On earnings-per-share growth, the picture is similar: Oceaneering International, Inc. grew EPS 142. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, CLOV leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oceaneering International, Inc.

(OII) is the more profitable company, earning 12. 7% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OII leads at 10. 9% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — OII leads at 20. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Oceaneering International, Inc.

(OII) trades at 20. 5x forward P/E versus 65. 9x for Clover Health Investments, Corp. — 45. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLOV: 18. 1% to $3. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Oceaneering International, Inc.

(OII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 06)). Both have compounded well over 10 years (OII: +16. 7%, CLOV: -72. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OII (Energy) and CLOV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OII is a small-cap deep-value stock; CLOV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.